Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Biochemical changes in sarcoidosis

U Costabel1, H Teschler

  • 1Department of Pneumology and Allergology, Ruhrlandklinik, Essen, Germany.

Clinics in Chest Medicine
|December 31, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparison of a 22G Crown-Cut Needle with a Conventional 22G Needle with EBUS Guidance in Diagnosis of Sarcoidosis.

Lung·2022
Same author

[Linguistic Validation of the "German Lung Fibrosis Health Related Quality of Life Questionnaire"].

Pneumologie (Stuttgart, Germany)·2021
Same author

[Update of the AWMF S2k Guideline "Diagnostics and Assessment of Occupational Asbestos-Related Diseases" - What's New?]

Pneumologie (Stuttgart, Germany)·2021
Same author

[Changes to the Law on Occupational Diseases and Consequences for Medical Assessment].

Pneumologie (Stuttgart, Germany)·2020
Same author

[German Guideline for Idiopathic Pulmonary Fibrosis].

Pneumologie (Stuttgart, Germany)·2020
Same author

Pneumologie (Stuttgart, Germany)·2020
Same journal

Pneumonia Reimagined: Host, Microbe, and the Shifting Landscape of Disease.

Clinics in chest medicine·2026
Same journal

Advocacy in Pneumonia.

Clinics in chest medicine·2026
Same journal

Vaccines Against Pneumonia: Current Updates.

Clinics in chest medicine·2026
Same journal

Non-antibiotic Treatments for Pneumonia: Host-Directed Therapies, Next-Steps and Future Directions.

Clinics in chest medicine·2026
Same journal

Customizing Antibiotic Treatment for Pneumonia: Can We Have a Single Unified Algorithm for All Types of Pneumonia?

Clinics in chest medicine·2026
Same journal

The Role of Complex Digital Interventions to Improve Pneumonia Care.

Clinics in chest medicine·2026
See all related articles

Biochemical markers in sarcoidosis reflect immune activity and inflammation. Only serum calcium and angiotensin-converting enzyme (ACE) levels are clinically proven for assessing sarcoidosis.

Area of Science:

  • Immunology
  • Biochemistry
  • Pulmonology

Background:

  • Biochemical markers in sarcoidosis correlate with immune responses and inflammation at granuloma sites.
  • Markers can be measured in serum (whole-body) or bronchoalveolar lavage (BAL) fluid (lung-specific).

Purpose of the Study:

  • To review the clinical utility of biochemical markers in sarcoidosis assessment.
  • To identify markers with proven diagnostic or prognostic value.

Main Methods:

  • Literature review of studies evaluating biochemical markers in sarcoidosis.
  • Analysis of marker levels in serum and BAL fluid.

Main Results:

  • Serum calcium and angiotensin-converting enzyme (ACE) levels have demonstrated clinical value.

Related Experiment Videos

  • Other markers reflect disease activity but lack proven clinical utility.

    • Conclusions:

    • Serum calcium and ACE are valuable biochemical markers for clinical management of sarcoidosis.
    • Further research may identify additional useful markers.